Cite Filings / MRKR
Feed Companies Filings Check
Sign in

CIK 0001094038

  • Non-accelerated filer
  • Smaller reporting company

Marker Therapeutics, Inc.

Sign in to watch
Ticker
MRKR
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
880277072
Phone
+1 713-400-6400
Business address
2450 HOLCOMBE BLVD, TMC PARTNERS OFFICE 1.311, HOUSTON, TX, 77021
Former names
TAPIMMUNE INC., TAPIMMUNE INC, GENEMAX CORP, EDUVERSE COM
Filings Financials Insiders Search text
All 905 Financials 298 Shareholder Meetings 19 Executive Compensation 245 Insider Trading 237 Beneficial Ownership Interest 92 Business Combinations 214 Public Offerings 104 Mutual Funds and ETFs 13 Others 166
›
Filed in
  1. No filings match these filters. Clear filters
  2. DEF 14A Proxy Proxy Statement 2026-03-20
  3. DEF 14A Proxy Proxy Statement 2025-04-24
  4. DEF 14A Proxy Proxy Statement 2025-02-04
  5. DEF 14A Proxy Proxy Statement 2024-04-26
  6. DEF 14A Proxy Proxy Statement 2023-04-28
  7. DEF 14A Proxy Proxy Statement 2022-04-15
  8. DEF 14A Proxy Proxy Statement 2021-04-23
  9. DEF 14A Proxy Proxy Statement 2020-04-17
  10. DEF 14A Proxy Proxy Statement 2019-03-28
  11. DEF 14A Proxy Proxy Statement 2017-07-12
  12. DEF 14A Proxy Proxy Statement 2008-12-30
  13. DEF 14A Proxy Proxy Statement 2007-03-02
  14. DEF 14A Proxy Proxy Statement 2004-03-16

Page 1 of 1 · 13 filings

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…